title: Preventing Long-Term Cardiac Damage in Pediatric Patients With Kawasaki Disease.
abstract: Kawasaki disease is currently the leading cause of long-term cardiac damage in pediatric patients in the United States. Kawasaki disease is diagnosed based on symptomatology and by ruling out other etiology. There is a significant need for an improved, standardized treatment protocol for patients diagnosed with Kawasaki disease and a more rapid initiation of treatment for these patients. Decreasing the cardiac damage caused by Kawasaki disease with timely diagnosis and treatment needs be a principal goal.
authors: Kelly
authors: K
authors: Williams
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D002648:Child; D003323:Coronary Aneurysm / Q000150:complications* / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000517:prevention & control*; D017023:Coronary Angiography; D042241:Early Diagnosis; D004452:Echocardiography; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications* / Q000503:physiopathology* / Q000628:therapy; D018570:Risk Assessment; D014657:Vasculitis / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000503:physiopathology
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D001241:Aspirin
keywords: Cardiac damage; Kawasaki disease; coronary artery aneurysm; fever; pediatrics